Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

How To choose first line therapy in melanoma?

In this 'How To' educational video , Riccardo Marconcini explains how to choose first line therapy for patients with advanced melanoma. Baseline evaluation including tumour burden staging, LDH, and biomarker testing should be performed to gather key information for prognosis grouping and treatment selection.

Reprinted from Lancet Oncology, 17 /12, Long GV et al., Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials, Copyright (2016), with permission from Elsevier

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.